Juha Lintunen

Title: Juha Lintunen: Innovator in Pharmaceutical Composition

Introduction

Juha Lintunen is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that target cancer treatment. His work is characterized by a focus on innovative solutions that address critical health challenges.

Latest Patents

Juha Lintunen holds a patent for a pharmaceutical composition of darolutamide. This invention relates to a formulation for oral administration, specifically in tablet form, which includes darolutamide or a pharmaceutically acceptable salt as the active ingredient. Darolutamide is recognized as a potent androgen receptor (AR) modulator, which is particularly useful in treating AR-dependent cancers, such as prostate cancer, and other diseases where AR antagonism is beneficial.

Career Highlights

Juha Lintunen is associated with Orion Corporation, a leading company in the pharmaceutical industry. His work at Orion has allowed him to contribute to the advancement of medical treatments that improve patient outcomes. His innovative approach and dedication to research have positioned him as a key figure in his field.

Collaborations

Juha collaborates with talented professionals, including Susanna Ilmonen and Petteri Lyytinen. These collaborations enhance the research and development process, fostering an environment of innovation and creativity.

Conclusion

Juha Lintunen's contributions to pharmaceutical compositions, particularly his work on darolutamide, highlight his role as an influential inventor in the medical field. His dedication to advancing cancer treatment through innovative solutions is commendable.